UK Vaping Association Calls for Stricter Regulations

Mar.23.2023
UK Vaping Association Calls for Stricter Regulations
The UK electronic cigarette industry faces a "glaring failure" as ELFBAR and Lost Mary products are recalled due to exceeding standard nicotine levels.

On March 22nd, the Electronic Cigarette Association of the UK announced that the withdrawal of ELFBAR and Lost Mary products with nicotine levels exceeding the legal limit demonstrated a "glaring failure" in the UK's electronic cigarette regulation framework.


John Dunne, the director general of UK Vaping Industry Association (UKVIA), has stated that it is now clear that approving e-cigarette products without compliance testing is not feasible, whether before or after approval.


He made the statement following a joint announcement from the Medicines and Healthcare products Regulatory Agency (MHRA) and the Chartered Trading Standards Institute (CTSI) in the UK. The products recalled include ELFBAR and Lost Mary brands.


Deng En stated, 'Although we are aware that mistakes may occur, we must do everything possible to ensure they happen as little as possible. Because, as we have seen in recent weeks, the reputation of the entire industry depends on it.'


During the MHRA approval process, there should be a testing plan in place for random sampling to ensure that products not only meet requirements upon initial market entry, but also maintain these standards over time.


We still need to see authorities taking swift and decisive action upon uncovering any violations of the law, in order to quickly correct mistakes and make it clear to manufacturers, distributors and retailers what actions they need to take.


He said that from the issue of excessive e-liquid to the announcement that non-compliant products must be taken down, these controversies have caused widespread confusion within the industry and among consumers.


Deng En noted that in order to maintain public confidence in the industry, retailers, distributors, and manufacturers must be aware that any non-compliant behavior will be taken seriously.


He added: "The MHRA should seriously consider the ECID numbers of products found to be non-compliant and suspend their authorization until the issue has been truly resolved.


This also highlights the need for a universal standard for compliance testing (such as e-cigarette e-liquid).


The UKVIA has obtained the independent test results of electronic cigarette products. Concerningly, conflicting results have been observed depending on the type of test conducted.


A recent joint statement by CTSI and MHRA has stated that on February 23, they advised law enforcement officers that, in accordance with Regulation 39 of the Tobacco and Related Products Regulations (TRPRs), all non-compliant E-Liquid Flavourings, Additives and Response products must be removed from sale.


There has been further communication between ElLFBAR and MHRA to update the corrective action plan and identify more affected batches, including some of the Lost Mary products.


CTSI and MHRA are pleased to note that compliant alternative products have now arrived in the country. We continue to expect all manufacturers to act responsibly and will promptly share any further information received with enforcement officials.


The joint statement additionally states that:


There is no evidence to suggest that using the ELFBAR or LostMary products, which have been overfilled with e-juice, poses a greater health risk during normal use.


The vigilance required in Article 39 is specifically applicable to non-compliant and unsafe products.


Products that do not meet requirements are not permitted to be sold to consumers.


If batches of products that do not meet requirements are still on the shelves, whether action should be taken is determined by the priorities, competitive demands, and available resources in the local area.


It said the affected batches are as follows:


Previous notice:


ELFBAR 600s with the following batch numbers: ep0i7693, ep020398, ep020250, ep019749, ep020257, ep019746, ep020120, ep020394, ep019893, ep019894.


Other Batches:


MaryBM600 has gone missing.


Taste: Watermelon, apple, kiwi, passionfruit, pomegranate, cotton candy ice cream, strawberry ice cream, blueberry sour raspberry.


Batch Numbers: LP017641, LP018253, LP019438, LP019923, LP020487, LP021149.


Mary QM600 has gone missing.


Taste: Grape and Cola.


Batch: LP017906 and LP016850.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

ZYN Nicotine Pouches Seek MRTP Authorization; FDA Sets January Meeting
ZYN Nicotine Pouches Seek MRTP Authorization; FDA Sets January Meeting
The U.S. FDA has scheduled a Tobacco Products Scientific Advisory Committee (TPSAC) meeting for January 22, 2026, to review Swedish Match USA’s Modified Risk Tobacco Product (MRTP) applications for 20 ZYN nicotine pouch products. Although the products gained PMTA authorization in early 2025, MRTP approval is required for marketing them with reduced-risk claims.
Nov.24 by 2FIRSTS.ai
France’s Top Administrative Court Suspends Nicotine Pouch Decree
France’s Top Administrative Court Suspends Nicotine Pouch Decree
France’s Council of State has suspended a government decree that was set to ban the manufacture, production and export of nicotine pouches from April 2026. The court ruled that companies were not given sufficient time to reorganise their operations. A final decision on the legality of the decree is expected by June 2026. The court noted that the commercial sale of nicotine pouches is already restricted under existing public health laws.
Dec.23 by 2FIRSTS.ai
British American Tobacco Introduces Facial Age Verification in Italy, Pilot Covers 119 Stores
British American Tobacco Introduces Facial Age Verification in Italy, Pilot Covers 119 Stores
British American Tobacco’s Italian unit is partnering with digital identity firm Yoti to pilot facial-scan age verification at 119 pop-up stores nationwide, aiming to supplement traditional ID checks and prevent underage purchases of tobacco and nicotine products.
Dec.25 by 2FIRSTS.ai
Sweden on Track to Become Europe’s First Smoke-Free Nation as Snus and Nicotine Pouches Support Declining Smoking Rates
Sweden on Track to Become Europe’s First Smoke-Free Nation as Snus and Nicotine Pouches Support Declining Smoking Rates
According to Gulf News, Sweden is nearing the World Health Organization’s smoke-free threshold, with daily smoking falling below 5%. Two decades of public health efforts and the growing use of lower-risk alternatives such as Snus and tobacco-free nicotine pouches have contributed to this shift, alongside declines in tobacco-related deaths and lung cancer cases.
Dec.04 by 2FIRSTS.ai
Exclusive: Altria Confirms FDA Grants Marketing Authorization to on! PLUS, Ending More Than a Year of PMTA Review
Exclusive: Altria Confirms FDA Grants Marketing Authorization to on! PLUS, Ending More Than a Year of PMTA Review
Altria on December 19 confirmed that six on! PLUS nicotine pouch products had received U.S. FDA marketing authorization, ending a PMTA review lasting more than a year after the company moved ahead with launch plans before clearance.
Regulations
Dec.20
2Firsts Interview | Bengt Wiberg: Why the Oral Health Risks of Nicotine Pouches Merit Further Study
2Firsts Interview | Bengt Wiberg: Why the Oral Health Risks of Nicotine Pouches Merit Further Study
As nicotine pouches gain global traction as a lower-risk alternative to smoking, questions are emerging about their potential oral health effects. In a 2Firsts interview, Stingfree AB founder Bengt Wiberg discusses why gum irritation and oral lesions warrant closer scrutiny within the broader framework of tobacco harm reduction.
Jan.06